News Alert: FDA pulls emergency authorization for antimalaria drug as covid-19 treatment, which had been touted by Trump

The Food and Drug Administration has withdrawn its emergency use authorization for hydroxychloroquine to treat coronavirus patients. President Trump had repeatedly promoted the antimalaria drug as a way to prevent or treat covid-19. The agency said in a statement that "it is no longer reasonable to believe" the drug may be effective against covid-19 or that its benefits outweigh "known and potential risks." The move comes after months of questions and criticisms about the FDA's authorization of the product, which can cause potential heart-rhythm problems.

Democracy Dies in Darkness     News Alert Jun 15, 12:20 PM     FDA pulls emergency authorization for antimalaria drug as covid-19 treatment, which had been touted by Trump The Food and Drug Administration has withdrawn its emergency use authorization for hydroxychloroquine to treat coronavirus patients. President Trump had repeatedly promoted the antimalaria drug as a way to prevent or treat covid-19. The agency said in a statement that "it is no longer reasonable to believe" the drug may be effective against covid-19 or that its benefits outweigh "known and potential risks." The move comes after months of questions and criticisms about the FDA's authorization of the product, which can cause potential heart-rhythm problems. Read more » Advertisement You received this email because you signed up for news alerts from The Washington Post. Manage my newsletters and alerts | Unsubscribe Privacy Policy | Help ©2020 The Washington Post, 1301 K St NW, Washington DC 20071